|
| |
| | | 55976 | | 25.06.2002 | | Sandoz Pharmaceuticals AG | | 25.06.2007 | | | | | | | | | | | 07.08.20. | | | | 07.08.20. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Estradot 37.5 | Transdermales Pflaster | Transdermal patch (Estradiol 585 µg) | G03CA03 | CI | | 02 | Estradot 50 | Transdermales Pflaster | Transdermal patch (Estradiol 780 µg) | G03CA03 | CI | | 03 | Estradot 75 | Transdermales Pflaster | Transdermal patch (Estradiol 1.17 mg) | G03CA03 | CI | | 04 | Estradot 100 | Transdermales Pflaster | Transdermal patch (Estradiol 1.56 mg) | G03CA03 | CI | | 05 | Estradot 25 | Transdermales Pflaster | Transdermal patch (Estradiol 390 µg) | G03CA03 | CI |
|
|
|
